Diabetes drug class linked to vision-threatening complication

Treatment with the glitazone class of diabetes drugs leads to a 'modest' increase in the risk of diabetic macular oedema (DME) - a common complication that can lead to vision loss, reports a study in the April issue of the American Journal of Ophthalmology, published by Elsevier...

Read the whole article on

More from